FDA Dings Chinese Drug Companies, Website

July 3, 2018, 4:23 PM UTC

Bloomberg Law tracks recent federal government administrative actions and warnings directed toward pharmaceutical and life sciences entities.

Jacobs Pills, Inc.

  • Issuing Office: Food and Drug Administration, Division of Pharmaceutical Quality Operations
  • Recipient: Philip Altman (supervising pharmacist)
  • Date: May 31, 2018 (posted July 3)
  • Inspection of facility in Elmsford, N.Y., Feb. 22-28, 2017

Alleged Infractions

  • Company does not have valid prescriptions for some of the drugs it produces.
  • Some drugs at the facility are compounded using melatonin and domperidone, which aren’t permissible under FDA regulations for compounded drugs.
  • Company uses ingredients that don’t comply with identity, strength, quality, and purity standards. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.